2Gonen Y,Jacobson W,Casper RF.Gonadotropin suppression with oral contraceptives before in vitro fertilization.Fertil Steril,1990,53:282-287.
3Palomba S,Falbo A,Negro S,et al.Use of oral contraceptives in infertile patients:A descriptive review.Gynecological Endocrinology,2006,22:537-546.
4Kolibianakis EM,Papanikolaou EG,Camus M,et al.Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF.A randomized controlled trial.Hum Reprod,2006,21:352-357.
5Rombauts L,Healy D,Norman RJ.orgalutran scheduling Study Group.A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.Human Reproduction,2006,21:95-103.
6The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Hum Reprod,2004,19:41-47.
7Hastings JM,Licence DR,Burton GJ,et al.Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17-Estradiol in the Mouse Uterus.Endocrinology,2003,144:326-334.
8Duvan CI,Berker B,Turhan NO,et al.Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients.J Assist Reprod Genet,2008,25:89-93.
9Boddy JL,Fox SB,Han C.The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a,HIF-2a,and the prolyl hydroxylases in human prostate cancer.Clin Cancer Res,2005,11:7658-7663.
10Ruohola JK,Valve EM,Karkkainen MJ.Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.Mol Cell Endocrinol,1999,149:29-40.
